R&D PHARMACEUTICALS LTD
Significant control: Riju Varghese (25–50%), Dipu Maruthananickal Thomas (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for R&D Pharmaceuticals Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does R&D Pharmaceuticals Ltd sell?
Registered activity: Dispensing chemist in specialised stores (SIC 47730). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
R&D PHARMACEUTICALS LTD is an active private limited company (company number 15271531) incorporated on 9 November 2023, registered in Weston-Super-Mare. Its registered activity is dispensing chemist in specialised stores (SIC 47730). Latest small accounts cover the period ending 30 November 2025, showing net assets of −£20k and cash of £51k, with 6 employees on average. Net assets fell 2% on the prior period (−£19k).
By net assets it sits in the bottom quarter of 59 comparable companies in Bristol (median £5,711, upper quartile £156k).
Ownership and control
- Mr Riju Varghese
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Dipu Maruthananickal Thomas
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 9 November 20232 yrs ago
- Next accounts due
- 30 August 2027in 306 days
- Confirmation statement due
- 23 November 2026in 26 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 47730
- Dispensing chemist in specialised stores
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | −£20k | £51k | £80k | — | — | — | 6 |
| 30 November 2024 | −£19k | £16k | £55k | — | — | — | 5 |
| 8 November 2023 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-19,752 at 30 November 2025
- Cash at bank of £50,000 or moreCash £50,516
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 9 November 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 306 days
- Confirmation statement duein 26 days
- Accounts period endNet liabilities £20k · small accounts
- Accounts period endNet liabilities £19k · small accounts
- Incorporated
- Accounts period end
Similar companies in Bristol
- WG HEALTHCARE LTDBristol · inc. Jan 2024
- TEKKDOSE LTDBristol · inc. Aug 2023
- VINAYAK PHARMA LTDBristol · inc. Feb 2024
- JOEL PHARMA LTDBristol · inc. Mar 2024
- STAZ HEALTHCARE LIMITEDBristol · inc. Mar 2024
- SULIS HEALTHCARE LIMITEDBath · inc. Jun 2023
All companies incorporated on 9 November 2023 · in Nov 2023.
Reminders for R&D PHARMACEUTICALS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.